IC

Ikarian Capital Portfolio holdings

AUM $699M
1-Year Est. Return 600.17%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+600.17%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$773M
AUM Growth
+$278M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
181
New
Increased
Reduced
Closed

Top Buys

1
+$33.1M
2
+$14.6M
3
+$14.3M
4
OLMA icon
Olema Pharmaceuticals
OLMA
+$13.5M
5
LLY icon
Eli Lilly
LLY
+$13.2M

Top Sells

1
+$53M
2
+$20.7M
3
+$16M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$13.6M
5
PTCT icon
PTC Therapeutics
PTCT
+$11.8M

Sector Composition

1 Healthcare 99.47%
2 Financials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYRA
126
DELISTED
LYRA THERAPEUTICS INC
LYRA
$65.2K 0.01%
21,161
JSPR icon
127
Jasper Therapeutics
JSPR
$14M
$44.1K 0.01%
24,093
-1,014
AEMD icon
128
Aethlon Medical
AEMD
$3.3M
$39.8K 0.01%
14,364
-1,002
RZLT icon
129
Rezolute
RZLT
$405M
$38.9K 0.01%
+16,479
PHGE icon
130
BiomX
PHGE
$8.72M
$36.4K ﹤0.01%
19,473
-1,210
AIRS icon
131
AirSculpt Technologies
AIRS
$364M
$32.5K ﹤0.01%
16,398
-1,553
TOVX icon
132
Theriva Biologics
TOVX
$12.7M
$23.6K ﹤0.01%
112,076
-7,955
SYBX
133
DELISTED
Synlogic
SYBX
$22.4K ﹤0.01%
19,966
-456
ANEB
134
DELISTED
Anebulo Pharmaceuticals
ANEB
$17.9K ﹤0.01%
17,736
-139,984
AMIX
135
Autonomix Medical
AMIX
$4.39M
$10.3K ﹤0.01%
18,688
-1,312
SNDX icon
136
Syndax Pharmaceuticals
SNDX
$1.63B
– –
-333,733
SONN
137
DELISTED
Sonnet BioTherapeutics
SONN
– –
-150,000
SPRY icon
138
ARS Pharmaceuticals
SPRY
$872M
– –
0
SRPT icon
139
Sarepta Therapeutics
SRPT
$1.72B
– –
0
AKRO
140
DELISTED
Akero Therapeutics
AKRO
– –
-206,854
ALT icon
141
Altimmune
ALT
$560M
– –
0
ANAB icon
142
AnaptysBio
ANAB
$1.47B
– –
-48,410
ANIP icon
143
ANI Pharmaceuticals
ANIP
$1.7B
– –
0
AQST icon
144
Aquestive Therapeutics
AQST
$498M
– –
0
ARCT icon
145
Arcturus Therapeutics
ARCT
$212M
– –
-10,721
ARGX icon
146
argenx
ARGX
$50.5B
– –
-5,942
BBIO icon
147
BridgeBio Pharma
BBIO
$12.8B
– –
-51,967
BMY icon
148
Bristol-Myers Squibb
BMY
$112B
– –
0
CNTA
149
Centessa Pharmaceuticals
CNTA
$6.17B
– –
0
COGT icon
150
Cogent Biosciences
COGT
$5.41B
– –
-11,280
4 5
6
7 8